Diagnosis, Diagnostic Test Accuracy (DTA) and Prognostic Reviews
- Deep vein thrombosis (DVT)
- Pulmonary embolism (PE)
Intervention Reviews
- Prevention of venous thromboembolism (VTE) in specific surgical/invasive procedure patients
- Prevention of VTE in acutely medically ill/high risk patients
- Prevention of VTE in other patient groups
- Prevention of post thrombotic syndrome (PTS)
- Treatment of VTE
- Treatment of DVT
- Treatment of PE
- Treatment of PTS
- Other
Diagnosis, Diagnostic Test Accuracy (DTA) and Prognosis reviews
Deep Vein Thrombosis (DVT)
Clinical decision rules for the diagnosis of deep vein thrombosis (title)
Diagnostic tests for pregnancy-related deep vein thrombosis (protocol)
Duplex ultrasound for the diagnosis of symptomatic deep vein thrombosis in the lower limb (protocol)
Ultrasonography for clinically suspected upper extremity deep vein thrombosis (protocol)
Pulmonary Embolism (PE)
D-dimer test for excluding the diagnosis of pulmonary embolism
Imaging for the exclusion of pulmonary embolism in pregnancy
Sex as a prognostic factor in patients with symptomatic acute pulmonary embolism (protocol)
Intervention reviews
Prevention of venous thromboembolism (VTE) in specific surgical/invasive procedure patient groups
Continuous passive motion for preventing venous thromboembolism after total knee arthroplasty
Direct thrombin inhibitors versus vitamin K antagonists or low molecular weight heparins for prevention of venous thromboembolism following total hip or knee replacement
Heparin dose for thrombosis prophylaxis during peripheral vascular angioplasty (protocol)
Interventions for the primary prevention of venous thromboembolism for hip fracture surgery (protocol)
Interventions for preventing venous thromboembolism following abdominal aortic surgery
Interventions for preventing venous thromboembolism in adults undergoing knee arthroscopy
Low molecular weight heparin for prevention of microvascular occlusion in digital replantation
Primary prophylaxis for venous thromboembolism in patients undergoing cardiac or thoracic surgery
Prevention of VTE in acutely medically ill/high risk patient groups
Heparin for the prevention of venous thromboembolism in acutely ill medical patients (excluding stroke and myocardial infarction)
Novel oral anticoagulants for prevention of venous thromboembolism in acutely ill medical patients (title)
Standard versus extended duration anticoagulation for primary venous thromboembolism prophylaxis in acutely ill medical patients (protocol)
Prevention of VTE in other patient groups
Compression stockings for preventing deep vein thrombosis in airline passengers
Graduated compression stockings for prevention of deep vein thrombosis
Heparin-bonded catheters for prolonging the patency of central venous catheters in children
Neuromuscular electrical stimulation for the prevention of venous thromboembolism
Pentasaccharides for the prevention of venous thromboembolism
Prevention of recurrent venous thromboembolism: an overview of Cochrane reviews (title)
Primary prophylaxis for venous thromboembolism in ambulatory cancer patients receiving chemotherapy
Prophylactic anticoagulants for non-hospitalised people with COVID-19 (protocol)
Statins for the prevention of primary venous thromboembolism (protocol)
Statins for primary prevention of venous thromboembolism
Vena caval filters for the prevention of pulmonary embolism
Prevention of Post Thrombotic Syndrome (PTS)
Compression therapy for prevention of post-thrombotic syndrome
Rutosides for prevention of post thrombotic syndrome
Treatment of VTE
Duration of treatment with vitamin K antagonists in symptomatic venous thromboembolism
Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for the initial treatment of venous thromboembolism
Subcutaneous unfractionated heparin for the initial treatment of venous thromboembolism
Treatment for superficial thrombophlebitis of the leg
Warfarin initiation nomograms for venous thromboembolism
Treatment of DVT
Angioplasty for deep venous thrombosis (protocol)
Antiplatelet agents for the treatment of deep venous thrombosis
Home versus in-patient treatment for deep vein thrombosis
Pentasaccharides for the treatment of deep vein thrombosis
Pharmacomechanical thrombectomy for iliofemoral deep vein thrombosis
Thrombolysis for acute upper extremity deep vein thrombosis
Treatment of distal deep vein thrombosis
Treatment of PE
Anticoagulant treatment for subsegmental pulmonary embolism
Catheter‐directed therapies for the treatment of high risk (massive) and intermediate risk (submassive) acute pulmonary embolism
Oral direct thrombin inhibitors or oral factor Xa inhibitors for the treatment of pulmonary embolism
Outpatient versus inpatient treatment for acute pulmonary embolism
Thrombolytic therapy for pulmonary embolism
Treatment of PTS
Compression therapy for treating post-thrombotic syndrome
Rutosides for treatment of post-thrombotic syndrome
Other
Thrombophilia testing for prevention of recurrent venous thromboembolism (stable)
Unfractionated heparin versus low molecular weight heparin for avoiding heparin-induced thrombocytopenia in postoperative patients